Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study

Objective To analyze the association of sleep duration and use of sleeping medication with multimorbidity. Materials and Methods We conducted a cross-sectional study using data from the Prospective Study about Mental and Physical Health (PAMPA) cohort. Multimorbidity was defined as the pr...

Full description

Bibliographic Details
Main Authors: Felipe Mendes Delpino, Eduardo L. Caputo, Ricardo Alexandre Arcêncio, Júlia Cassuriaga, Caroline Malue Huckembeck, Bruno Pereira Nunes, Airton José Rombaldi, Felipe Fossati Reichert, Marcelo Cozzensa da Silva, Natan Feter
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2023-03-01
Series:Sleep Science
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1767757
_version_ 1797368167543078912
author Felipe Mendes Delpino
Eduardo L. Caputo
Ricardo Alexandre Arcêncio
Júlia Cassuriaga
Caroline Malue Huckembeck
Bruno Pereira Nunes
Airton José Rombaldi
Felipe Fossati Reichert
Marcelo Cozzensa da Silva
Natan Feter
author_facet Felipe Mendes Delpino
Eduardo L. Caputo
Ricardo Alexandre Arcêncio
Júlia Cassuriaga
Caroline Malue Huckembeck
Bruno Pereira Nunes
Airton José Rombaldi
Felipe Fossati Reichert
Marcelo Cozzensa da Silva
Natan Feter
author_sort Felipe Mendes Delpino
collection DOAJ
description Objective To analyze the association of sleep duration and use of sleeping medication with multimorbidity. Materials and Methods We conducted a cross-sectional study using data from the Prospective Study about Mental and Physical Health (PAMPA) cohort. Multimorbidity was defined as the presence of two or more conditions from a list of twelve health problems. Descriptive analyses were performed considering proportion and its 95% confidence interval (95%CI). We performed logistic regression (to obtain odds ratios, ORs) to estimate the associations, including models adjusted for confounding factors. Results In total, 2,936 participants were included, 79,1% of them women, 54.2% aged between 18 and 39 years, and 88.9% with white skin color. Compared with regular sleep (seven to eight hours a day), five hours or less of sleep increased the odds of multimorbidity by 145% (95%CI: 1.90–3.14), and 9 hours or more of sleep increased the odds by 49% (95%CI: 1.14–1.95) for the crude model; the results remained significant even in the adjusted models. Discussion Consumption of sleeping medication was associated with multimorbidity. Short and prolonged sleep duration increased the odds of multimorbidity, regardless of the sociodemographic and behavior characteristics. The regular use of sleeping medication was also associated with multimorbidity. The results of the present study are important but require caution due to reverse causality, and longitudinal studies are needed to confirm the findings.
first_indexed 2024-03-08T17:28:47Z
format Article
id doaj.art-7eb4610dd2884ac4a0a07400c3b65379
institution Directory Open Access Journal
issn 1984-0659
1984-0063
language English
last_indexed 2024-03-08T17:28:47Z
publishDate 2023-03-01
publisher Thieme Revinter Publicações Ltda.
record_format Article
series Sleep Science
spelling doaj.art-7eb4610dd2884ac4a0a07400c3b653792024-01-02T17:21:57ZengThieme Revinter Publicações Ltda.Sleep Science1984-06591984-00632023-03-01160106807410.1055/s-0043-1767757Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort StudyFelipe Mendes Delpino0Eduardo L. Caputo1Ricardo Alexandre Arcêncio2Júlia Cassuriaga3Caroline Malue Huckembeck4Bruno Pereira Nunes5Airton José Rombaldi6Felipe Fossati Reichert7Marcelo Cozzensa da Silva8Natan Feter9Federal University of Pelotas, Postgraduate Program in Nursing, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilUniversity of São Paulo, Postgraduate Program in Nursing in Public Health, São Paulo, São Paulo, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Nursing, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilFederal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, BrazilObjective To analyze the association of sleep duration and use of sleeping medication with multimorbidity. Materials and Methods We conducted a cross-sectional study using data from the Prospective Study about Mental and Physical Health (PAMPA) cohort. Multimorbidity was defined as the presence of two or more conditions from a list of twelve health problems. Descriptive analyses were performed considering proportion and its 95% confidence interval (95%CI). We performed logistic regression (to obtain odds ratios, ORs) to estimate the associations, including models adjusted for confounding factors. Results In total, 2,936 participants were included, 79,1% of them women, 54.2% aged between 18 and 39 years, and 88.9% with white skin color. Compared with regular sleep (seven to eight hours a day), five hours or less of sleep increased the odds of multimorbidity by 145% (95%CI: 1.90–3.14), and 9 hours or more of sleep increased the odds by 49% (95%CI: 1.14–1.95) for the crude model; the results remained significant even in the adjusted models. Discussion Consumption of sleeping medication was associated with multimorbidity. Short and prolonged sleep duration increased the odds of multimorbidity, regardless of the sociodemographic and behavior characteristics. The regular use of sleeping medication was also associated with multimorbidity. The results of the present study are important but require caution due to reverse causality, and longitudinal studies are needed to confirm the findings.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1767757diseasesmultimorbiditysleepsleep deprivation
spellingShingle Felipe Mendes Delpino
Eduardo L. Caputo
Ricardo Alexandre Arcêncio
Júlia Cassuriaga
Caroline Malue Huckembeck
Bruno Pereira Nunes
Airton José Rombaldi
Felipe Fossati Reichert
Marcelo Cozzensa da Silva
Natan Feter
Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study
Sleep Science
diseases
multimorbidity
sleep
sleep deprivation
title Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study
title_full Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study
title_fullStr Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study
title_full_unstemmed Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study
title_short Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study
title_sort association of sleep duration and use of sleeping medication with multimorbidity in adults results from the pampa brazil cohort study
topic diseases
multimorbidity
sleep
sleep deprivation
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1767757
work_keys_str_mv AT felipemendesdelpino associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy
AT eduardolcaputo associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy
AT ricardoalexandrearcencio associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy
AT juliacassuriaga associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy
AT carolinemaluehuckembeck associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy
AT brunopereiranunes associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy
AT airtonjoserombaldi associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy
AT felipefossatireichert associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy
AT marcelocozzensadasilva associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy
AT natanfeter associationofsleepdurationanduseofsleepingmedicationwithmultimorbidityinadultsresultsfromthepampabrazilcohortstudy